Editorial: achievements and unresolved questions in improving the pharmacokinetics of vedolizumab in adolescents with inflammatory bowel disease

Stephanie A. Vuijk; Lissy de Ridder

doi:10.1111/apt.17321

Editorial: achievements and unresolved questions in improving the pharmacokinetics of vedolizumab in adolescents with inflammatory bowel disease

Stephanie A. Vuijk
, Lissy de Ridder^*

^*Corresponding author for this work

Pediatrics

Research output: Contribution to journal › Editorial › Academic › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	565-566
Number of pages	2
Journal	Alimentary Pharmacology and Therapeutics
Volume	57
Issue number	5
DOIs	https://doi.org/10.1111/apt.17321
Publication status	Published - Mar 2023

Bibliographical note

Funding Information:
Declaration of personal interests: S.A. Vuijk: TISKids study was supported by ZonMw, Crocokids and an Investigator-Sponsored Research Award from Pfizer. L. de Ridder: Collaboration with Abbvie, Lilly, Takeda, Janssen and Pfizer. Grant from ZonMw, ECCO, Pfizer.

Funding Information:
S.A. Vuijk: TISKids study was supported by ZonMw, Crocokids and an Investigator‐Sponsored Research Award from Pfizer. L. de Ridder: Collaboration with Abbvie, Lilly, Takeda, Janssen and Pfizer. Grant from ZonMw, ECCO, Pfizer. Declaration of personal interests:

Access to Document

10.1111/apt.17321

Cite this

@article{6878c24ad73b4a6eaa4ed977dd2f01d2,

title = "Editorial: achievements and unresolved questions in improving the pharmacokinetics of vedolizumab in adolescents with inflammatory bowel disease",

author = "Vuijk, \{Stephanie A.\} and \{de Ridder\}, Lissy",

note = "Funding Information: Declaration of personal interests: S.A. Vuijk: TISKids study was supported by ZonMw, Crocokids and an Investigator-Sponsored Research Award from Pfizer. L. de Ridder: Collaboration with Abbvie, Lilly, Takeda, Janssen and Pfizer. Grant from ZonMw, ECCO, Pfizer. Funding Information: S.A. Vuijk: TISKids study was supported by ZonMw, Crocokids and an Investigator‐Sponsored Research Award from Pfizer. L. de Ridder: Collaboration with Abbvie, Lilly, Takeda, Janssen and Pfizer. Grant from ZonMw, ECCO, Pfizer. Declaration of personal interests:",

year = "2023",

month = mar,

doi = "10.1111/apt.17321",

language = "English",

volume = "57",

pages = "565--566",

journal = "Alimentary Pharmacology and Therapeutics",

issn = "0269-2813",

publisher = "John Wiley \& Sons Inc.",

number = "5",

}

TY - JOUR

T1 - Editorial

T2 - achievements and unresolved questions in improving the pharmacokinetics of vedolizumab in adolescents with inflammatory bowel disease

AU - Vuijk, Stephanie A.

AU - de Ridder, Lissy

N1 - Funding Information: Declaration of personal interests: S.A. Vuijk: TISKids study was supported by ZonMw, Crocokids and an Investigator-Sponsored Research Award from Pfizer. L. de Ridder: Collaboration with Abbvie, Lilly, Takeda, Janssen and Pfizer. Grant from ZonMw, ECCO, Pfizer. Funding Information: S.A. Vuijk: TISKids study was supported by ZonMw, Crocokids and an Investigator‐Sponsored Research Award from Pfizer. L. de Ridder: Collaboration with Abbvie, Lilly, Takeda, Janssen and Pfizer. Grant from ZonMw, ECCO, Pfizer. Declaration of personal interests:

PY - 2023/3

Y1 - 2023/3

UR - https://www.scopus.com/pages/publications/85147990806

U2 - 10.1111/apt.17321

DO - 10.1111/apt.17321

M3 - Editorial

C2 - 36786458

AN - SCOPUS:85147990806

SN - 0269-2813

VL - 57

SP - 565

EP - 566

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

IS - 5

ER -

Editorial: achievements and unresolved questions in improving the pharmacokinetics of vedolizumab in adolescents with inflammatory bowel disease

Bibliographical note

Access to Document

Other files and links

Cite this